Anhui Fengyuan Pharmaceutical Co Ltd (000153) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.033x

Based on the latest financial reports, Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥69.15 Million ≈ $10.12 Million USD) by net assets (CN¥2.13 Billion ≈ $311.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000153 equity financing ratio to measure how much of total assets are equity-financed.

Anhui Fengyuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Anhui Fengyuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000153 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Anhui Fengyuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Fengyuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Taiwan Mask Corp
TW:2338
0.116x
Enseval Putra Megatrading Tbk
JK:EPMT
0.035x
Lanpec Technologies Ltd
SHG:601798
0.028x
Tesco PLC
LSE:TSCO
0.152x
GENERALFINANCE SPA
F:VG30
-0.212x
China Bicycle Co Holdings Ltd
SHE:000017
-0.042x
Plumas Bancorp
NASDAQ:PLBC
0.021x
Shanghai Yahong Moulding Co Ltd
SHG:603159
0.056x

Annual Cash Flow Conversion Efficiency for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Anhui Fengyuan Pharmaceutical Co Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.13 Billion
≈ $311.10 Million
CN¥119.30 Million
≈ $17.46 Million
0.056x -9.06%
2024-12-31 CN¥2.05 Billion
≈ $299.38 Million
CN¥126.24 Million
≈ $18.47 Million
0.062x -53.53%
2023-12-31 CN¥1.92 Billion
≈ $280.78 Million
CN¥254.75 Million
≈ $37.28 Million
0.133x -47.05%
2022-12-31 CN¥1.75 Billion
≈ $256.78 Million
CN¥439.99 Million
≈ $64.38 Million
0.251x +64.19%
2021-12-31 CN¥1.56 Billion
≈ $227.94 Million
CN¥237.88 Million
≈ $34.81 Million
0.153x -24.47%
2020-12-31 CN¥1.45 Billion
≈ $211.88 Million
CN¥292.75 Million
≈ $42.84 Million
0.202x +305.23%
2019-12-31 CN¥1.33 Billion
≈ $194.20 Million
CN¥66.21 Million
≈ $9.69 Million
0.050x -72.41%
2018-12-31 CN¥1.29 Billion
≈ $189.03 Million
CN¥233.59 Million
≈ $34.18 Million
0.181x +321.21%
2017-12-31 CN¥1.22 Billion
≈ $178.59 Million
CN¥52.40 Million
≈ $7.67 Million
0.043x -36.72%
2016-12-31 CN¥1.15 Billion
≈ $168.69 Million
CN¥78.21 Million
≈ $11.44 Million
0.068x +76.59%
2015-12-31 CN¥1.18 Billion
≈ $173.29 Million
CN¥45.50 Million
≈ $6.66 Million
0.038x +319.25%
2014-12-31 CN¥1.15 Billion
≈ $167.83 Million
CN¥10.51 Million
≈ $1.54 Million
0.009x +113.74%
2013-12-31 CN¥1.05 Billion
≈ $154.28 Million
CN¥-70.31 Million
≈ $-10.29 Million
-0.067x -213.22%
2012-12-31 CN¥775.01 Million
≈ $113.41 Million
CN¥45.65 Million
≈ $6.68 Million
0.059x -18.14%
2011-12-31 CN¥765.24 Million
≈ $111.98 Million
CN¥55.06 Million
≈ $8.06 Million
0.072x -1.45%
2010-12-31 CN¥753.81 Million
≈ $110.31 Million
CN¥55.04 Million
≈ $8.05 Million
0.073x +52.92%
2009-12-31 CN¥678.70 Million
≈ $99.31 Million
CN¥32.41 Million
≈ $4.74 Million
0.048x -37.32%
2008-12-31 CN¥654.09 Million
≈ $95.71 Million
CN¥49.82 Million
≈ $7.29 Million
0.076x -11.93%
2007-12-31 CN¥638.89 Million
≈ $93.49 Million
CN¥55.26 Million
≈ $8.09 Million
0.086x +47.97%
2006-12-31 CN¥620.49 Million
≈ $90.80 Million
CN¥36.27 Million
≈ $5.31 Million
0.058x +0.49%
2005-12-31 CN¥599.59 Million
≈ $87.74 Million
CN¥34.88 Million
≈ $5.10 Million
0.058x +393.43%
2004-12-31 CN¥591.07 Million
≈ $86.49 Million
CN¥-11.72 Million
≈ $-1.71 Million
-0.020x +0.35%
2003-12-31 CN¥576.00 Million
≈ $84.29 Million
CN¥-11.46 Million
≈ $-1.68 Million
-0.020x -206.51%
2002-12-31 CN¥560.87 Million
≈ $82.07 Million
CN¥10.48 Million
≈ $1.53 Million
0.019x -57.51%
2001-12-31 CN¥536.15 Million
≈ $78.46 Million
CN¥23.57 Million
≈ $3.45 Million
0.044x -9.55%
2000-12-31 CN¥532.50 Million
≈ $77.92 Million
CN¥25.88 Million
≈ $3.79 Million
0.049x +154.14%
1999-12-31 CN¥52.98 Million
≈ $7.75 Million
CN¥1.01 Million
≈ $148.25K
0.019x --

About Anhui Fengyuan Pharmaceutical Co Ltd

SHE:000153 China Drug Manufacturers - Specialty & Generic
Market Cap
$366.51 Million
CN¥2.50 Billion CNY
Market Cap Rank
#13678 Global
#3953 in China
Share Price
CN¥5.39
Change (1 day)
+2.47%
52-Week Range
CN¥5.02 - CN¥7.61
All Time High
CN¥22.93
About

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.